FRANKFURT (dpa-AFX) - After good business figures, Dermapharm shares briefly climbed to a high since September 2022 on Monday at 46.70 euros. The shares of the specialist for dermatology and allergology gained at times over 6 percent. Most recently, they were still up a good 4 percent.

In a first reaction, Jefferies expert Alexander Thiel praised the strong results of the first quarter. The expectations were clearly topped, all areas had contributed to it, the expert said. He had already raised his estimates in his outlook./ag/mis